[Federal Register: June 17, 2003 (Volume 68, Number 116)]
[Notices]
[Page 35892-35894]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr17jn03-63]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Program Announcement 03094]
Perinatal HIV Prevention in the United States: National
Organizations Working Toward Elimination; Notice of Availability of
Funds
Application Deadline: August 1, 2003.
A. Authority and Catalog of Federal Domestic Assistance Number
This program is authorized under section 301(a) and 317K(2) of the
Public Health Service Act, (42 U.S.C. 241(a) and 274b (k)(2)), as
amended. The Catalog of Federal Domestic Assistance number is 93.943.
B. Purpose
The Centers for Disease Control and Prevention (CDC) announces the
availability of fiscal year (FY) 2003 funds for a cooperative agreement
program for ``Perinatal HIV Prevention in the United States: National
Organizations Working Toward Elimination.'' This program addresses the
``Healthy People 2010'' focus area(s) of HIV and Maternal, Infant and
Child Health.
The purpose of this program is to: (1) Develop, provide and
disseminate technical assistance and other educational and training
materials needed to improve perinatal HIV prevention efforts
nationally; (2) promote the integration of: universal voluntary HIV
testing into prenatal care across the United States, rapid HIV testing
for women with unknown HIV status in labor, and offering repeat HIV
testing to women at risk for seroconversion during pregnancy; and (3)
foster the exchange of information, ideas and experiences of perinatal
HIV prevention among maternal and child health providers, HIV care
providers and consumers.
Measurable outcomes of the program will be in alignment with one or
more of the following performance goals for the National Center for
HIV, STD and TB Prevention (NCHSTP): (1) Reduce the number of new HIV
infections; (2) increase the proportion of HIV-infected people who know
they are infected; (3) increase the proportion of HIV-infected people
who are linked to appropriate prevention, care, and treatment services;
and (4) strengthen the capacity nationwide to monitor the epidemic,
develop and implement effective HIV prevention interventions and
evaluate prevention programs.
C. Eligible Applicants
Applications may be submitted by national organizations having
demonstrated experience providing needs assessments, capacity building,
curricula, and training about prevention of mother to child
transmission of HIV (PMTCT) for consumers and health care workers,
including: Pediatricians, obstetricians, family practitioners, nurses,
nurse-midwives, nurse practitioners, counselors, health educators,
PMTCT program managers, and other health care providers. These national
organizations may be:
[sbull] Public nonprofit organizations
[sbull] Private nonprofit organizations
[sbull] Faith-based organizations
This program is limited to national organizations that have the
capability to serve the broadest U.S. audiences by supporting national
efforts to assure consistent messages in training and education.
Note: Title 2 of the United States Code section 1611 states that
an organization described in section 501(C)(4) of the Internal
Revenue Code that engages in lobbying activities is not eligible to
receive Federal funds constituting an award, grant or loan.
D. Funding
Availability of Funds
Approximately $700,000 is available in FY 2003, to fund
approximately three to four awards. It is expected that the average
award will be $175,000, ranging from $50,000 to $225,000. It is
expected that the awards will begin on or about September 15, 2003, and
will be made for a 12-month budget period within a project period of up
to four years. Funding estimates may change.
Continuation awards within an approved project period will be made
on the basis of satisfactory progress as evidenced by required reports
and the availability of funds.
Use of Funds
Funds from this cooperative agreement should not be used for major
purchase of equipment or construction. Requests for equipment such as
computers and Liquid Crystal Display (LCD) Projectors for training
require detailed justification.
Recipient Financial Participation
Matching funds are not required for this program.
Funding Preferences
Funding preference will be given to national organizations with
prior experience providing training to health care providers regarding:
(1) Incorporation of PMTCT into health care provider education; (2)
offering of universal voluntary HIV testing to pregnant women as a
routine part of prenatal care; (3) implementation of voluntary rapid
HIV testing programs in labor and delivery settings; and (4) to
national organizations that have developed and disseminated patient
educational materials on HIV, perinatal HIV and its prevention.
E. Program Requirements
In conducting activities to achieve the purpose of this program,
the recipient will be responsible for the activities listed in 1.
Recipient Activities and CDC will be responsible for the activities
listed in 2. CDC Activities.
1. Recipient Activities
a. Provide training and technical assistance to programs and health
care providers in sharing and applying knowledge and expertise
regarding HIV prevention and perinatal transmission. Specifically,
disseminate educational materials, and provide training and technical
assistance on approaches to help providers achieve high rates of
prenatal HIV testing by using recommended HIV screening practices
including opt-out strategies, offering rapid HIV testing for women in
labor who present with undocumented HIV status and linking HIV-at risk
and HIV-infected women and their infants to comprehensive medical and
social services.
b. Sponsor a variety of forums for presentation of information on
HIV perinatal reduction (i.e., policies, programs, materials, and other
technical
[[Page 35893]]
information) and other public health information related to HIV
prevention and pregnancy among Maternal and Child Health (MCH)
populations.
c. Collaborate with other funded national organizations and the
CDC, Division of HIV/AIDS and other Centers, Institutes, and Offices
(CIOs) within CDC which address HIV prevention relevant to MCH
populations, to assess needs and provide technical assistance.
d. Participate in an annual CDC-sponsored meeting on perinatal HIV
prevention.
2. CDC Activities
a. Facilitate and assist in the development of training materials
and curricula, administrative tools and policy manuals.
b. Participate in defining the scope of perinatal HIV transmission
and other prevention needs relevant to MCH populations, and provide
information and technical assistance in meeting those needs.
c. Work with each awardee to facilitate and support collaboration
among funded national organizations as well as CDC-funded perinatal HIV
prevention and surveillance programs.
d. Provide a synthesis of known best practices and interventions
regarding prevention of perinatal transmission of HIV for all pregnant
women, including women with little or no prenatal care and unknown HIV
status at labor and delivery.
e. Collaborate in the development of forums that focus on perinatal
HIV transmission and other public health information that relates to
HIV prevention among maternal-child health populations.
f. Assist in the evaluation of perinatal HIV prevention education,
training, and materials.
g. Collaborate in the presentation and publication of evaluation
findings.
h. Conduct site visits to monitor progress of the programs.
F. Content
Applications
The Program Announcement title and number must appear in the
application. Use the information in the Program Requirements, Other
Requirements, and Evaluation Criteria sections to develop the
application content. Your application will be evaluated on the criteria
listed, so it is important to follow them in laying out your program
plan. The narrative should be no more than 18 pages, single-spaced,
printed on one side, with one-inch margins, and unreduced 12-point
font.
The narrative should consist of:
1. Abstract (not to exceed one page): An executive summary of your
program covered under this announcement.
2. Program Plan (Not to exceed 17 pages): In developing the
application under this announcement, please review the recipient
activities and, in particular, evaluation criteria and respond
concisely and completely. The program plan should address activities to
be conducted over the entire four-year budget period.
3. Budget: Submit an itemized budget and supporting justification
that is consistent with your proposed program plan.
G. Submission and Deadline
Application Forms
Submit the signed original and two copies of PHS 5161-1 (OMB Number
0920-0428). Forms are available at the following Internet address:
http://www.cdc.gov/od/pgo/forminfo.htm.
If you do not have access to the Internet, or if you have
difficulty accessing the forms on-line, you may contact the CDC
Procurement and Grants Office Technical Information Management Section
(PGO-TIM) at: 770-488-2700. Application forms can be mailed to you.
Submission Date, Time, and Address:
The application must be received by 4 p.m. Eastern Time August 1,
2003. Submit the application to: Technical Information Management-
PA 03094, CDC Procurement and Grants Office, 2920 Brandywine
Road, Atlanta, GA 30341-4146.
Applications may not be submitted electronically.
CDC Acknowledgement of Application Receipt
A postcard will be mailed by PGO-TIM, notifying you that CDC has
received your application.
Deadline
Applications shall be considered as meeting the deadline if they
are received before 4 p.m. Eastern Time on the deadline date. Any
applicant who sends their application by the United States Postal
Service or commercial delivery services must ensure that the carrier
will be able to guarantee delivery of the application by the closing
date and time. If an application is received after closing due to (1)
carrier error, when the carrier accepted the package with a guarantee
for delivery by the closing date and time, or (2) significant weather
delays or natural disasters, CDC will upon receipt of proper
documentation, consider the application as having been received by the
deadline.
Any application that does not meet the above criteria will not be
eligible for competition, and will be discarded. The applicant will be
notified of their failure to meet the submission requirements.
H. Evaluation Criteria
Application
Applicants are required to provide measures of effectiveness that
will demonstrate the accomplishment of the various identified
objectives of the cooperative agreement regarding educational material
and training on perinatal HIV prevention. Measures of effectiveness
must relate to the performance goals stated in the purpose section of
this announcement. Measures must be objective and quantitative and must
measure the intended outcome. These measures of effectiveness must be
submitted with the application and will be an element of evaluation.
An independent review group appointed by CDC will evaluate each
application against the following criteria:
1. Scope of Plan (30 points): a succinct statement of the intent
and desired outcome(s) of the project and clearly stated and measurable
outcome objectives to be achieved by the project. These objectives must
be quantifiable in terms of outputs and time frame for achievement. The
statement of intent and outcome objectives should address the purpose
of the cooperative agreement, which is to: (1) Develop, provide and
disseminate technical assistance and other educational and training
materials needed to improve perinatal HIV prevention efforts
nationally; (2) promote the integration of universal voluntary HIV
testing into prenatal care across the United States, rapid HIV testing
for women with unknown HIV status in labor, and offering repeat HIV
testing to women at risk for seroconversion during pregnancy; and (3)
foster the exchange of information, ideas and experiences of perinatal
HIV prevention among maternal and child health providers, HIV care
providers and consumers.
2. Personnel and Staffing (30 points): the qualifications and
experience of key personnel, other professional staff and support staff
available to carry out the perinatal HIV prevention activities.
3. Methods (25 points): Clear statement of approach and activities
required to achieve the stated perinatal HIV prevention outcome
objectives. The relationship between activities and objectives must be
explicitly demonstrated. Description of activities must include a
delineation of resources required, identification of the personnel
[[Page 35894]]
who will perform the work, and a management plan with description of
the systems and procedures which will be used to manage the progress,
budget and operations of the project.
4. Evaluation (15 points): Detailed plans for evaluating the degree
to which the program achieves the purpose of the cooperative agreement
(as listed in the purpose section, and above in the description of the
scope of plan.) Measures must be objective and quantitative and must
measure the intended outcome. The submission of these measures shall be
a data element to be submitted with, or incorporated into the
semiannual progress reports.
5. Budget (reviewed, but not scored): There is an upper limit of
$250,000. An application submitted with a budget over $250,000, will be
reviewed and, if awarded, only partially funded. The budget will be
reviewed to determine the extent to which it is reasonable, clearly
justified, consistent with the intended use of the funds, and
allowable. All budget categories should be itemized.
I. Other Requirements
Technical Reporting Requirements
Provide CDC with original plus two copies of:
1. Interim progress report, no less than 90 days before the end of
the budget period. The progress report will serve as your non-competing
continuation application, and must contain the following elements:
a. Current Budget Period Activities Objectives.
b. Current Budget Period Financial Progress.
c. New Budget Period Program Proposed Activity Objectives.
d. Detailed Line-Item Budget and Justification.
e. Additional Requested Information.
2. Financial status report, no more than 90 days after the end of
the budget period.
3. Final financial and performance reports, no more than 90 days
after the end of the project period.
Send all reports to the Grants Management Specialist identified in
the ``Where to Obtain Additional Information'' section of this
announcement.
Additional Requirements
The following additional requirements are applicable to this
program. For a complete description of each, see Attachment I of the
program announcement, as posted on the CDC Web site.
AR-4 HIV/AIDS Confidentiality Provisions
AR-5 HIV Program Review Panel Requirements
AR-7 Executive Order 12372 Review
AR-9 Paperwork Reduction Act Requirements
AR-10 Smoke-Free Workplace Requirements
AR-11 Healthy People 2010
AR-12 Lobbying Restrictions
AR-14 Accounting System Requirements
AR-21 Small, Minority, and Women-Owned Business
AR-22 Research Integrity
J. Where To Obtain Additional Information
This and other CDC announcements, the necessary applications, and
associated forms can be found on the CDC Web site, Internet address:
http://www.cdc.gov. Click on ``Funding'' then ``Grants and Cooperative
Agreements''.
For general questions about this announcement, contact: Technical
Information Management, CDC Procurement and Grants Office, 2920
Brandywine Road, Atlanta, GA 30341-4146, Telephone: 770-488-2700.
For business management and budget assistance, contact: Carlos Smiley,
Grants Management Specialist, Procurement and Grants Office, Centers
for Disease Control and Prevention, 2920 Brandywine Road, Atlanta, GA
30341-4146, Telephone: 770-488-2722, E-mail address: anx3@cdc.gov.For program technical assistance, contact: Margaret A. Lampe, RN,
Project Officer, Division of HIV/AIDS Prevention, Centers for Disease
Control and Prevention, 1600 Clifton Road, Mailstop E-45, Atlanta, GA
30333, Telephone: 404-639-5189, E-mail address: m1ampe@cdc.gov.
Dated: June 7, 2003.
Sandra R. Manning,
Director, Procurement and Grants Office, Centers for Disease Control
and Prevention.
[FR Doc. 03-15217 Filed 6-16-03; 8:45 am]
BILLING CODE 4163-18-P